Daily Morning Note – 12 November 2020


European shares rose for a third straight day on Wednesday as optimism around a potential Covid-19 vaccine and encouraging comments from European Central Bank chief Christine Lagarde offset worries of economic damage from surging infections. The pan-European Stoxx 600 jumped 1 percent, building on a 6 percent rally this week as investors bought into utilities as well as travel-related stocks, a sector that has widely underperformed this year.

Technology stocks, which have tracked a surge in their US counterparts since the coronavirus-driven crash in March, gained 2 per cent.

The benchmark Stoxx 600 has surged nearly 45 per cent since March, thanks partly to historic global stimulus, but it is still down 6.5 per cent on the year as the resurgence in Covid-19 cases threatens a nascent economic recovery.

By comparison, the US benchmark S&P 500 has risen nearly 10 per cent this year and was propelled to record highs this week after drugmaker Pfizer Inc said its Covid-19 vaccine was 90 per cent effective.


The board of the manager of Sabana Shari’ah Compliant Industrial Real Estate Investment Trust on Wednesday said it is considering the requisition notice from Quarz Capital and Black Crane Capital and seeking legal advice, adding that it will make further announcements on SGXNet in due course.

Fraser and Neave (F&N) on Wednesday posted a 2.1 percent dip in net profit to S$149.2 million, as revenue also fell 3.6 percent to S$1.8 billion for its full-year ended Sept 30. Its revenue was hit by lower volumes from its soft drinks and publishing businesses, it said.

UOL Group on Wednesday said headwinds remain, although its retail portfolio’s committed occupancy remains stable, with average daily footfall in the third quarter having recovered to 54 percent of pre-Covid levels. In the first nine months of 2020, shopper footfall fell 43.1 percent from the levels in the year before. Committed occupancy at the end of September was 93.5 percent, from 94.4 percent at the end of June.

SBS Transit on Wednesday posted a 3.3 percent dip in post-tax profit to S$19.36 million for its third quarter ended Sept 30. Without the Covid-19 government reliefs, it would have recorded an operating loss of S$4.04 million. Revenue for the quarter fell 17 percent to S$301.99 million, mainly due to lower service fees, lower rail ridership and lower advertising revenue.

Jiutian Chemical Group on Wednesday posted another record set of results – a Q3 attributable net profit of RMB51.9 million (S$10.5 million) for the three months ended Sept 30, compared to just RMB2.4 million a year ago. This was also a significant jump from its RMB32.6 million net profit reported in the preceding quarter – in itself a record quarterly net profit since the firm was listed in 2006.

Best World International on Wednesday posted a 13.7 percent increase in its third-quarter net profit to S$28.2 million, as revenue for the three months ended Sept 30 rose 14.8 per cent to S$131.3 million. This was helped to an extent by lower cost of sales, largely due to lower import duties incurred in China from the temporary preferential custom duty rates obtained by the Hunan branch of its China subsidiary; this resulted in a substantially lower custom duty rate for the quarter, it said. Earnings per share rose to 5.19 Singapore cents for the quarter, compared to 4.56 cents a year ago.

DBS Private Bank (PB) is recording a strong response to its family-office services as the pandemic drives greater awareness of the need for wealth structuring, tax planning and philanthropic outreach. Since the unit was established last year, the number of these privately held companies managing the wealth and investments of wealthy families which it has helped set up has more than doubled; assets under management (AUM) have grown by 40 percent.

Global oil benchmark Brent rose on Wednesday, briefly touching a more than two-month high above US$45 a barrel on hopes of a Covid-19 vaccine that could boost demand and later pulling back as concerns about rising cases overtook bullish news. Brent settled up 19 cents, or 0.4 percent, at US$43.80 a barrel, after earlier trading at a session peak of US$45.30 – the first time it has cleared the US$45 threshold since early September. US West Texas Intermediate (WTI) crude settled up 9 cents at US$41.45, after setting a session high of US$43.06.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR


Keppel DC REIT

Analyst: Chua Wei Ren

Recommended Action: Technical BUY

Keppel DC REIT (SGX: AJBU) bullish outlook is resuming based on the technical, after a period of consolidation.

Mapletree Industrial Trust

Analyst: Chua Wei Ren

Recommended Action: Technical BUY

Mapletree Industrial Trust (SGX: ME8U) bullish outlook is set to continue despite a continuation of selling the past 2 days and technical is showing signs of a bullish return.

>> Read more Technical reports


Webinar Of The Week

Market Outlook: (PSR) StarHub, Banks & REIT Results, Banking Monthly, Credit Commentary, SG Weekly & more

Date: 09 November 2020

For more on Market Outlook

Updates summarised in 3 minutes

Phillip Research in 3 minutes: #26 – iX Biopharma Ltd; Initiation

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com